FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 343:1846-1850 December 21, 2000 Number 25 Next

	Full Text PDF Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Little is known about the prognosis of cancer discovered during or after an episode of venous thromboembolism.

Methods We linked the Danish National Registry of Patients, the Danish Cancer Registry, and the Danish Mortality Files to obtain data on the survival of patients who received a diagnosis of cancer at the same time as or after an episode of venous thromboembolism. Their survival was compared with that of patients with cancer who did not have venous thromboembolism (control patients), who were matched in terms of type of cancer, age, sex, and year of diagnosis.

Results Of 668 patients who had cancer at the time of an episode of deep venous thromboembolism, 44.0 percent of those with data on the spread of disease (563 patients) had distant metastasis, as compared with 35.1 percent of 5371 control patients with data on spread (prevalence ratio, 1.26; 95 percent confidence interval, 1.13 to 1.40). In the group with cancer at the time of venous thromboembolism, the one-year survival rate was 12 percent, as compared with 36 percent in the control group (P<0.001), and the mortality ratio for the entire follow-up period was 2.20 (95 percent confidence interval, 2.05 to 2.40). Patients in whom cancer was diagnosed within one year after an episode of venous thromboembolism had a slightly increased risk of distant metastasis at the time of the diagnosis (prevalence ratio, 1.23 [95 percent confidence interval, 1.08 to 1.40]) and a relatively low rate of survival at one year (38 percent, vs. 47 percent in the control group; P<0.001).

Conclusions Cancer diagnosed at the same time as or within one year after an episode of venous thromboembolism is associated with an advanced stage of cancer and a poor prognosis.

Source Information

From the Departments of Clinical Epidemiology and Medicine V, Aarhus University Hospital and Aalborg Hospital, Aarhus, Denmark (H.T.S.); the Danish Cancer Society, Institute of Cancer Epidemiology, Copenhagen, Denmark (L.M., J.H.O.); and the Departments of Medicine and Community and Family Medicine, Dartmouth Medical School, Hanover, N.H. (J.A.B.).

Address reprint requests to Dr. Sørensen at the Department of Clinical Epidemiology, Aarhus University Hospital, Vennelyst Blvd. 6, Bldg. 260, DK-8000 Aarhus C, Denmark, or at hts{at}soci.au.dk.

Full Text of this Article

This article has been cited by other articles:

• Ku, G. H., White, R. H., Chew, H. K., Harvey, D. J., Zhou, H., Wun, T. (2009). Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival. Blood 113: 3911-3917 [Abstract] [Full Text]  
• BABU, B., CARMAN, T. L. (2009). Cancer and clots: All cases of venous thromboembolism are not treated the same. Cleveland Clinic Journal of Medicine 76: 129-135 [Abstract] [Full Text]  
• Khorana, A. A., Lyman, G. H. (2009). Incidence and Prevention of Cancer-associated Thrombosis. Am Soc Clin Oncol Ed Book 2009: 321-325 [Abstract] [Full Text]  
• Ay, C., Simanek, R., Vormittag, R., Dunkler, D., Alguel, G., Koder, S., Kornek, G., Marosi, C., Wagner, O., Zielinski, C., Pabinger, I. (2008). High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). Blood 112: 2703-2708 [Abstract] [Full Text]  
• Ornstein, D. L. (2008). A Nickel's Worth of Cancer. ANN INTERN MED 149: 350-352 [Full Text]  
• Akl, E. A., Terrenato, I., Barba, M., Sperati, F., Sempos, E. V., Muti, P., Cook, D. J., Schunemann, H. J. (2008). Low-Molecular-Weight Heparin vs Unfractionated Heparin for Perioperative Thromboprophylaxis in Patients With Cancer: A Systematic Review and Meta-analysis. Arch Intern Med 168: 1261-1269 [Abstract] [Full Text]  
• Fotopoulou, C., duBois, A., Karavas, A. N., Trappe, R., Aminossadati, B., Schmalfeldt, B., Pfisterer, J., Sehouli, J. (2008). Incidence of Venous Thromboembolism in Patients With Ovarian Cancer Undergoing Platinum/Paclitaxel-Containing First-Line Chemotherapy: An Exploratory Analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group. JCO 26: 2683-2689 [Abstract] [Full Text]  
• Geerts, W. H., Bergqvist, D., Pineo, G. F., Heit, J. A., Samama, C. M., Lassen, M. R., Colwell, C. W. (2008). Prevention of Venous Thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133: 381S-453S [Abstract] [Full Text]  
• Khorana, A. A., Kuderer, N. M., Culakova, E., Lyman, G. H., Francis, C. W. (2008). Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 111: 4902-4907 [Abstract] [Full Text]  
• Brown, E. N., Herrington, J. D. (2008). Review of the Relationship Between Venous Thromboembolism, Malignancy and Its Treatment. Journal of Pharmacy Practice 21: 126-137 [Abstract]  
• Nguyen, D., Lee, S.-J., Libby, E., Verschraegen, C. (2008). Rate of Thromboembolic Events in Mesothelioma. Ann. Thorac. Surg. 85: 1032-1038 [Abstract] [Full Text]  
• Khorana, A. A., Liebman, H. A., White, R. H., Wun, T., Lyman, G. H. (2008). The Risk of Venous Thromboembolism in Patients with Cancer. Am Soc Clin Oncol Ed Book 2008: 240-248 [Abstract] [Full Text]  
• Falanga, A., Lee, A. Y. Y., Streiff, M. B., Lyman, G. H. (2008). Anticoagulation in the Treatment of Venous Thromboembolism in Patients with Cancer. Am Soc Clin Oncol Ed Book 2008: 258-268 [Abstract] [Full Text]  
• Lyman, G. H., Khorana, A. A., Falanga, A., Clarke-Pearson, D., Flowers, C., Jahanzeb, M., Kakkar, A., Kuderer, N. M., Levine, M. N., Liebman, H., Mendelson, D., Raskob, G., Somerfield, M. R., Thodiyil, P., Trent, D., Francis, C. W. (2007). American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer. JCO 25: 5490-5505 [Abstract] [Full Text]  
• Khorana, A. A. (2007). The NCCN Clinical Practice Guidelines on Venous Thromboembolic Disease: Strategies for Improving VTE Prophylaxis in Hospitalized Cancer Patients. The Oncologist 12: 1361-1370 [Abstract] [Full Text]  
• Mandala, M., Reni, M., Cascinu, S., Barni, S., Floriani, I., Cereda, S., Berardi, R., Mosconi, S., Torri, V., Labianca, R. (2007). Venous thromboembolism predicts poor prognosis in irresectable pancreatic cancer patients. Ann Oncol 18: 1660-1665 [Abstract] [Full Text]  
• Mandala, M., Moro, C., Labianca, R., Ferretti, G. (2007). Erlotinib in Pancreatic Cancer Patients: Do We Need More Information From the NCIC CTG Trial?. JCO 25: 4320-4321 [Full Text]  
• Loberg, R. D., Bradley, D. A., Tomlins, S. A., Chinnaiyan, A. M., Pienta, K. J. (2007). The Lethal Phenotype of Cancer: The Molecular Basis of Death Due to Malignancy. CA Cancer J Clin 57: 225-241 [Abstract] [Full Text]  
• Cronin, C. G., Lohan, D. G., Keane, M., Roche, C., Murphy, J. M. (2007). Prevalence and Significance of Asymptomatic Venous Thromboembolic Disease Found on Oncologic Staging CT. Am. J. Roentgenol. 189: 162-170 [Abstract] [Full Text]  
• Nishioka, J., Goodin, S. (2007). Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival. J Oncol Pharm Pract 13: 85-97 [Abstract]  
• Paz-Priel, I., Long, L., Helman, L. J., Mackall, C. L., Wayne, A. S. (2007). Thromboembolic Events in Children and Young Adults With Pediatric Sarcoma. JCO 25: 1519-1524 [Abstract] [Full Text]  
• Simanek, R., Vormittag, R., Hassler, M., Roessler, K., Schwarz, M., Zielinski, C., Pabinger, I., Marosi, C. (2007). Venous thromboembolism and survival in patients with high-grade glioma. Neuro Oncol 9: 89-95 [Abstract] [Full Text]  
• Chew, H. K., Wun, T., Harvey, D. J., Zhou, H., White, R. H. (2007). Incidence of Venous Thromboembolism and the Impact on Survival in Breast Cancer Patients. JCO 25: 70-76 [Abstract] [Full Text]  
• Fennerty, A (2006). Venous thromboembolic disease and cancer.. Postgrad. Med. J. 82: 642-648 [Abstract] [Full Text]  
• Costenbader, K. H., Fidias, P., Gilman, M. D., Qureshi, A., Tambouret, R. H. (2006). Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 29-2006. A 43-year-old woman with painful nodules on the fingertips, shortness of breath, and fatigue.. NEJM 355: 1263-1272 [Full Text]  
• Alcalay, A., Wun, T., Khatri, V., Chew, H. K., Harvey, D., Zhou, H., White, R. H. (2006). Venous Thromboembolism in Patients With Colorectal Cancer: Incidence and Effect on Survival. JCO 24: 1112-1118 [Abstract] [Full Text]  
• (2006). Thromboembolism after pneumonectomy for malignancy: An independent marker of poor outcome.. J. Thorac. Cardiovasc. Surg. 131: 711-718  
• Chew, H. K., Wun, T., Harvey, D., Zhou, H., White, R. H. (2006). Incidence of venous thromboembolism and its effect on survival among patients with common cancers.. Arch Intern Med 166: 458-464 [Abstract] [Full Text]  
• Khorana, A. A., Francis, C. W., Culakova, E., Fisher, R. I., Kuderer, N. M., Lyman, G. H. (2006). Thromboembolism in Hospitalized Neutropenic Cancer Patients. JCO 24: 484-490 [Abstract] [Full Text]  
• Lee, A. Y. Y. (2006). Thrombosis and Cancer: The Role of Screening for Occult Cancer and Recognizing the Underlying Biological Mechanisms. ASH Education Book 2006: 438-443 [Abstract] [Full Text]  
• Kindler, H. L., Friberg, G., Singh, D. A., Locker, G., Nattam, S., Kozloff, M., Taber, D. A., Karrison, T., Dachman, A., Stadler, W. M., Vokes, E. E. (2005). Phase II Trial of Bevacizumab Plus Gemcitabine in Patients With Advanced Pancreatic Cancer. JCO 23: 8033-8040 [Abstract] [Full Text]  
• Trujillo-Santos, J., Perea-Milla, E., Jimenez-Puente, A., Sanchez-Cantalejo, E., del Toro, J., Grau, E., Monreal, M., for the RIETE Investigators, (2005). Bed Rest or Ambulation in the Initial Treatment of Patients With Acute Deep Vein Thrombosis or Pulmonary Embolism: Findings From the RIETE Registry. Chest 127: 1631-1636 [Abstract] [Full Text]  
• Falanga, A., Zacharski, L. (2005). Deep vein thrombosis in cancer: the scale of the problem and approaches to management. Ann Oncol 16: 696-701 [Abstract] [Full Text]  
• Kockar, C., Kockar, O., Ozturk, M., Dagli, M., Bavbek, N., Kosar, A. (2005). Global Fibrinolytic Capacity Increased Exponentially in Metastatic Colorectal Cancer. CLIN APPL THROMB HEMOST 11: 227-230 [Abstract]  
• Lee, A. Y.Y., Rickles, F. R., Julian, J. A., Gent, M., Baker, R. I., Bowden, C., Kakkar, A. K., Prins, M., Levine, M. N. (2005). Randomized Comparison of Low Molecular Weight Heparin and Coumarin Derivatives on the Survival of Patients With Cancer and Venous Thromboembolism. JCO 23: 2123-2129 [Abstract] [Full Text]  
• Blom, J. W., Doggen, C. J. M., Osanto, S., Rosendaal, F. R. (2005). Malignancies, Prothrombotic Mutations, and the Risk of Venous Thrombosis. JAMA 293: 715-722 [Abstract] [Full Text]  
• Zacharski, L. R., Prandoni, P., Monreal, M. (2005). Warfarin Versus Low-Molecular-Weight Heparin Therapy in Cancer Patients. The Oncologist 10: 72-79 [Abstract] [Full Text]  
• Davis, M. P. (2004). Hematology in palliative medicine. AM J HOSP PALLIAT CARE 21: 445-454 [Abstract]  
• Lopez, J. A., Kearon, C., Lee, A. Y.Y. (2004). Deep Venous Thrombosis. ASH Education Book 2004: 439-456 [Abstract] [Full Text]  
• Goldenberg, N., Kahn, S. R., Solymoss, S. (2003). Markers of Coagulation and Angiogenesis in Cancer-Associated Venous Thromboembolism. JCO 21: 4194-4199 [Abstract] [Full Text]  
• Lee, A. Y.Y., Levine, M. N. (2003). Venous Thromboembolism and Cancer: Risks and Outcomes. Circulation 107: I-17-21 [Abstract] [Full Text]  
• Lam, M. S H, Ignoffo, R. J (2003). A guide to clinically relevant drug interactions in oncology. J Oncol Pharm Pract 9: 45-85 [Abstract]  
• (2003). British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax 58: 470-483 [Full Text]  
• Ozturk, M., Sengul, N., Dagli, M., Kosar, A., Bavbek, N. (2003). Global Fibrinolytic Capacity in Colorectal Cancer: A New Clue to Occult Fibrinolysis. CLIN APPL THROMB HEMOST 9: 151-154 [Abstract]  
• Deitcher, S. R, Gomes, M. P. (2003). Hypercoagulable state testing and malignancy screening following venous thromboembolic events. Vasc Med 8: 33-46 [Abstract]  
• Samuels, M. A., King, M. E., Balis, U. (2002). Case 31-2002 - A 61-Year-Old Man with Headache and Multiple Infarcts. NEJM 347: 1187-1194 [Full Text]  
• Meyer, G., Marjanovic, Z., Valcke, J., Lorcerie, B., Gruel, Y., Solal-Celigny, P., Le Maignan, C., Extra, J. M., Cottu, P., Farge, D. (2002). Comparison of Low-Molecular-Weight Heparin and Warfarin for the Secondary Prevention of Venous Thromboembolism in Patients With Cancer: A Randomized Controlled Study. Arch Intern Med 162: 1729-1735 [Abstract] [Full Text]  
• Fennerty, T. (2001). Screening for cancer in venous thromboembolic disease. BMJ 323: 704-705 [Full Text]